Volume 2 Supplement 1

2005 International Meeting of The Institute of Human Virology

Open Access

Development of Vaginal Lactobacilli for Mucosal Delivery of a Topical Microbicide, Cyanovirin-N (CV-N)

  • Laurel Lagenaur1Email author,
  • Xiaowen Liu1,
  • David A Simpson1,
  • Kirsten Essenmacher1,
  • Courtney Parker1,
  • Chia-Hwa Chang1,
  • Daniel Tsai1,
  • Srinivas Rao2,
  • Dean Hamer3,
  • Thomas P Parks1,
  • Peter P Lee1, 4 and
  • Qiang Xu1
Retrovirology20052(Suppl 1):S93

DOI: 10.1186/1742-4690-2-S1-S93

Published: 8 December 2005

Background

Women are particularly at risk of HIV infection, therefore, female initiated strategies are essential to curtail the HIV/AIDS pandemic worldwide.

Material and Methods

We developed a live topical microbicide, which is an H2O2-producing Lactobacillus jensenii, a natural component of the vaginal microflora, as a delivery vehicle for the potent HIV inhibitor, cyanovirin-N (CV-N).

Results

The optimized CV-N expression cassette was stably integrated in single copy into the lactobacillus bacterial chromosome, and resolved from extraneous plasmid DNA and antibiotic resistance determinants. The L. jensenii-expressed CV-N dramatically decreased CCR5-trophic HIVBaL infectivity in vitro, with an IC50 of 0.3 nM. Histological examination of CD1 mice, which were intra-vaginally inoculated with L. jensenii expressing CV-N, revealed that L. jensenii was associated with keratinized epithelium present during estrus or free in the vaginal lumen and secreted full-length CV-N in vivo.

Conclusion

This live microbicide represents a major step towards developing inexpensive, durable protein-based microbicides to address the urgent need for female-controlled approaches to block the heterosexual transmission of HIV.

Notes

Authors’ Affiliations

(1)
Osel, Inc., 1800 Wyatt Dr., Ste. 14
(2)
Laboratory Animal Medicine, VRC, NIH
(3)
National Cancer Institute, NIH
(4)
Dept. of Medicine, Stanford University

Copyright

© The Author(s) 2005

Advertisement